title: Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Atzeni
authors.forename: Pietro
authors.initials: P
authors.lastname: Leccese
authors.forename: Salvatore
authors.initials: S
authors.lastname: D'Angelo
authors.forename: Piercarlo
authors.initials: P
authors.lastname: Sarzi-Puttini
authors.forename: Ignazio
authors.initials: I
authors.lastname: Olivieri
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D007871:Leg Ulcer / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000069285:Infliximab; D000068879:Adalimumab; D008727:Methotrexate